...
首页> 外文期刊>Journal of Oleo Science >Coix lacryma-jobi Seed Oil Reduces Fat Accumulation in Nonalcoholic Fatty Liver Disease by Inhibiting the Activation of the p-AMPK/SePP1/ apoER2 Pathway
【24h】

Coix lacryma-jobi Seed Oil Reduces Fat Accumulation in Nonalcoholic Fatty Liver Disease by Inhibiting the Activation of the p-AMPK/SePP1/ apoER2 Pathway

机译:Coix Lacryma-Jobi种子油通过抑制P-AMPK / SEPP1 / apoer2途径的激活来减少非酒精性脂肪肝疾病的脂肪积累

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The lipid metabolism disorder is the key role of Nonalcoholic fatty liver disease (NAFLD). Selenoprotein P plays an important role in the pathological process of lipid accumulation. Coix lacryma-jobi seed oil (CLSO) is an active component extracted from Coix lacryma-jobi seed (CLS) which has been found to be effective of reducing blood fat and antioxidative. But the effect and mechanism of CLSO on NAFLD are not clear. The aim of this study was to explore the therapeutic effect and mechanism of CLSO in the treatment of NAFLD. Our result showed that CLSO decreased the liver/body weight ratio, lowered the total cholesterol (TC) and triacylglycerol (TG), and elevated the high density lipoprotein (HDL) in serum. CLSO reduced the lipid deposition in the liver of NAFLD rats. In addition, CLSO could bring down the abnormal expression of superoxide dismutase (SOD) and malondialdehyde (MDA). Moreover, CLSO significantly declined the liver apolipoprotein E (apoE), apolipoprotein E receptor (apoER) and selenoprotein P 1 (SePP1) expression. In vivo, CLSO decreased the lipid droplets and TG level, reduced the protein expression of SePP1, apoER, phosphor-adenosine 5'-monophosphate (AMP)-activated protein kinase (p-AMPK) in the cytoplasm of HepG2 cells induced by oleic acid and palmitic acid (OP). At the same time, lipid accumulation was observed in the Sepp1 high expression cells induced by endoplasmic reticulum (ER) activator tunicamycin (Tm). CLSO could identically reduce the protein expression of SePP1, apoER, p-AMPK in the cytoplasm of HepG2 cells induced by Tm. This result not only proved the CLSO had therapeutic effect on NAFLD, but also confirmed its mechanism associated with degrading the phosphorylation of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) which led to the decrease of the expression SePP1/apoER2 in order to reduce lipid accumulation. The study suggests CLSO has great medicinal value in treating NAFLD besides its edibility.
机译:脂质代谢紊乱是非酒精性脂肪性肝病(NAFLD)的关键作用。硒蛋白p播放脂质堆积的病理过程中起重要作用。薏苡籽油(CLSO)是从薏苡的种子(CLS)中提取的活性成分,其已被发现是有效的降血脂和抗氧化的。但在NAFLD的影响,CLSO的机制尚不清楚。本研究的目的是探讨CLSO在NAFLD的治疗中的治疗效果和机制。我们的结果表明,CLSO肝脏/体重比下降,降低总胆固醇(TC)和三酰基甘油(TG),并升高血清中的高密度脂蛋白(HDL)。 CLSO在NAFLD大鼠肝脏减少脂质沉积。此外,CLSO可以减低超氧化物歧化酶(SOD)和丙二醛(MDA)的异常表达。此外,CLSO显著下降肝脏载脂蛋白E(载脂蛋白E),载脂蛋白E受体(apoER)和硒蛋白P 1(SEPP1)的表达。在体内,CLSO降低脂滴和TG水平,减少的SEPP1,apoER的蛋白的表达,荧光体的腺苷5'-一磷酸(AMP)在HepG2细胞中的由油酸诱导的细胞质中活化的蛋白激酶(P-AMPK)和棕榈酸(OP)。与此同时,在通过内质网(ER)活化剂衣霉素(Tm)的诱导SEPP1高表达细胞中观察到的脂质积聚。 CLSO可以相同减少通过的Tm诱导HepG2细胞的细胞质中SEPP1,apoER,对AMPK蛋白的表达。这一结果不仅证明了CLSO对NAFLD的治疗效果,而且还证实了降解腺苷单磷酸5'-(AMP)激活的蛋白激酶(AMPK),而导致表达SEPP1 / apoER2的减少的磷酸化相关的机制为了减少脂肪积累。这项研究表明CLSO在治疗脂肪肝除了其可食性很大的药用价值。

著录项

  • 来源
    《Journal of Oleo Science》 |2021年第5期|685-696|共12页
  • 作者单位

    Shandong University of Traditional Chinese Medicine Jinan CHINA;

    Shandong University of Traditional Chinese Medicine Jinan CHINA Shandong Provincial Chinese Medicine Classical Prescription Demonstration Engineering Technology Research Center Jinan CHINA;

    Shandong University of Traditional Chinese Medicine Jinan CHINA;

    Shandong University of Traditional Chinese Medicine Jinan CHINA Shandong Co-Innovation Center of Classic TCM formula Shandong University of Traditional Chinese Medicine Jinan CHINA;

    Shandong University of Traditional Chinese Medicine Jinan CHINA Shandong Co-Innovation Center of Classic TCM formula Shandong University of Traditional Chinese Medicine Jinan CHINA;

    Shandong University of Traditional Chinese Medicine Jinan CHINA;

    Shandong University of Traditional Chinese Medicine Jinan CHINA Shandong Provincial Chinese Medicine Classical Prescription Demonstration Engineering Technology Research Center Jinan CHINA;

    Department of Endocrinology Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan CHINA;

    Shandong University of Traditional Chinese Medicine Jinan CHINA;

    Shandong University of Traditional Chinese Medicine Jinan CHINA;

    Shandong University of Traditional Chinese Medicine Jinan CHINA;

    Department of Gastroenterology Shandong Provincial Qianfoshan Hospital the First Hospital Affiliated with Shandong First Medical University Jinan CHINA;

    Shandong University of Traditional Chinese Medicine Jinan CHINA Shandong Co-Innovation Center of Classic TCM formula Shandong University of Traditional Chinese Medicine Jinan CHINA Shandong Provincial Chinese Medicine Classical Prescription Demonstration Engineering Technology Research Center Jinan CHINA;

    Shandong University of Traditional Chinese Medicine Jinan CHINA Shandong Co-Innovation Center of Classic TCM formula Shandong University of Traditional Chinese Medicine Jinan CHINA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    nonalcoholic fatty liver disease (NAFLD); Coix lacryma-jobi seed oil (CLSO); hepatokine; selenoprotein P; antioxidant; high-fat diet;

    机译:非酒精性脂肪肝病(NAFLD);Coix Lacryma-Jobi种子油(CLSO);肝运动量;Selenoprotein p;抗氧化剂;高脂饮食;

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号